Genes have to be expressed in the right place, at the time, and at the right levels. Scientists wanted to know more about how ...

Biocytin was infused from recording pipette. Fixed sections visualized with FITC -conjugated streptavidin (green) and in situ HCR for Galanin mRNA Alexa Fluor 647 -conjugated hairpin DNA (#S23) ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell? It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor ...

Strengthened financial position by amending HCRx agreement to incrementally add up to $100 million In March 2025, Liquidia entered into an amendment to its agreement with HCRx (HCR Agreement ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

Together, we intend to accelerate the field of next-generation medicines in mRNA and CRISPR, using best-in-class chemistries, processes, and proprietary technologies like CleanCap ® analogs ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price ...

A team at Memorial Sloan Kettering has been working to improve those outcomes by developing a new mRNA vaccine for pancreatic cancer. A few years ago, the team embarked on a small trial to test the ...